Michael Masoomi, Latifah Al-Kandari, Iman Al-Shammeri, Hany Elrahman, Jehan Al-Shammeri
{"title":"A 3-year national DRL for CT in hybrid imaging study in Kuwait health environment-impact and implementation.","authors":"Michael Masoomi, Latifah Al-Kandari, Iman Al-Shammeri, Hany Elrahman, Jehan Al-Shammeri","doi":"10.1093/bjro/tzae032","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Diagnostic reference levels (DRLs) for CT in PET-CT are limited, and published DRLs from other countries may not be directly applicable to the State of Kuwait (KW). The authors aimed to carry out the final phase of a 3-year study on DRLs in KW, supporting optimization and dose reduction as imaging technology advances.</p><p><strong>Methods: </strong>In this cohort study, 400 adult oncology patients from 8 PET-CT centres were included, following the same procedures as in the first (2018) and second (2020) years, in accordance with the MOH-KW Ethical Committee's recommendations. The CT dose index (CTDIvol), dose-length product (DLP), and scan length were recorded, and the median, mean, standard deviation, as well as the 75th and 25th percentiles, along with the whole-body (WB) effective dose (ED), were calculated. Comparative studies were conducted to track implementation and identify any shortfalls.</p><p><strong>Results: </strong>In this study, half-body (HB) and WB scans accounted for 66% and 34% of the total 400 cases, respectively. The proposed local DRL practice among the 8 centres in the 2022 study exhibited a maximum variation of 25%, showing a 30% improvement over 2020. The achievable local DRL remained consistent with 2020 levels. Comparative results of the third quartile DLP (476 mGy cm) and CTDIvol (4 mGy) values for 2022 indicated lower values for the third phase (400 entries) compared to 2020, with a 1.5-fold variation in DLP. The calculated ED for WB scans ranged from 2.6 to 7.1 mSv, with mean values of 4.7 ± 1.25 mSv, using a conversion factor (<i>k</i> = 0.0093 mSv/mGy/cm). The 2022 proposed national diagnostic reference levels (NDRLs) for HB (469 mGy cm, 4.0 mGy) were lower than the Swiss National Data (620 mGy cm, 6.0 mGy) and France (628 mGy cm, 6.6 mGy), but slightly higher than those of the United Kingdom (400 mGy cm, 4.3 mGy), despite the Swiss having about 5000 entries, France 1000 entries, and the United Kingdom 370 HB entries.</p><p><strong>Conclusions: </strong>There was a 11.1% continuous improvement in NDRL for 2022 compared to 9.1% in 2020 and 13% in 2018, demonstrating a trend of enhanced optimization.</p><p><strong>Advances in knowledge: </strong>The data established a trend of NDRL for WBCT (PET-CT) that can serve as a national databank for ongoing optimization. This promotes improvements in patient protection and quality care within the clinical environment of the State of Kuwait, aligning with the strategic goals of Kuwait Vision-2035.</p>","PeriodicalId":72419,"journal":{"name":"BJR open","volume":"6 1","pages":"tzae032"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495866/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJR open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bjro/tzae032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Diagnostic reference levels (DRLs) for CT in PET-CT are limited, and published DRLs from other countries may not be directly applicable to the State of Kuwait (KW). The authors aimed to carry out the final phase of a 3-year study on DRLs in KW, supporting optimization and dose reduction as imaging technology advances.
Methods: In this cohort study, 400 adult oncology patients from 8 PET-CT centres were included, following the same procedures as in the first (2018) and second (2020) years, in accordance with the MOH-KW Ethical Committee's recommendations. The CT dose index (CTDIvol), dose-length product (DLP), and scan length were recorded, and the median, mean, standard deviation, as well as the 75th and 25th percentiles, along with the whole-body (WB) effective dose (ED), were calculated. Comparative studies were conducted to track implementation and identify any shortfalls.
Results: In this study, half-body (HB) and WB scans accounted for 66% and 34% of the total 400 cases, respectively. The proposed local DRL practice among the 8 centres in the 2022 study exhibited a maximum variation of 25%, showing a 30% improvement over 2020. The achievable local DRL remained consistent with 2020 levels. Comparative results of the third quartile DLP (476 mGy cm) and CTDIvol (4 mGy) values for 2022 indicated lower values for the third phase (400 entries) compared to 2020, with a 1.5-fold variation in DLP. The calculated ED for WB scans ranged from 2.6 to 7.1 mSv, with mean values of 4.7 ± 1.25 mSv, using a conversion factor (k = 0.0093 mSv/mGy/cm). The 2022 proposed national diagnostic reference levels (NDRLs) for HB (469 mGy cm, 4.0 mGy) were lower than the Swiss National Data (620 mGy cm, 6.0 mGy) and France (628 mGy cm, 6.6 mGy), but slightly higher than those of the United Kingdom (400 mGy cm, 4.3 mGy), despite the Swiss having about 5000 entries, France 1000 entries, and the United Kingdom 370 HB entries.
Conclusions: There was a 11.1% continuous improvement in NDRL for 2022 compared to 9.1% in 2020 and 13% in 2018, demonstrating a trend of enhanced optimization.
Advances in knowledge: The data established a trend of NDRL for WBCT (PET-CT) that can serve as a national databank for ongoing optimization. This promotes improvements in patient protection and quality care within the clinical environment of the State of Kuwait, aligning with the strategic goals of Kuwait Vision-2035.